An International Consensus Survey of Diagnostic Criteria for Macrophage Activation Syndrome in Systemic Juvenile Idiopathic Arthritis

被引:102
作者
Davi, Sergio [1 ]
Consolaro, Alessandro [1 ]
Guseinova, Dinara [1 ]
Pistorio, Angela [1 ]
Ruperto, Nicolino [1 ]
Martini, Alberto [1 ,2 ]
Cron, Randy Q. [3 ,4 ]
Ravelli, Angelo [1 ,2 ]
机构
[1] Ist Ricovero & Cura Carattere Sci G Gaslini, Genoa, Italy
[2] Univ Genoa, Genoa, Italy
[3] Childrens Hosp Alabama, Birmingham, AL USA
[4] Univ Alabama Birmingham, Birmingham, AL USA
关键词
MACROPHAGE ACTIVATION SYNDROME; HEMOPHAGOCYTIC SYNDROME; SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS; HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS; DIAGNOSTIC CRITERIA; DISEASE-ACTIVITY; RHEUMATOID-ARTHRITIS; LUPUS-ERYTHEMATOSUS; DERMATOMYOSITIS; GUIDELINES;
D O I
10.3899/jrheum.100996
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. To identify candidate diagnostic criteria for macrophage activation syndrome (MAS) complicating systemic juvenile idiopathic arthritis (sJIA) using international consensus formation through a Delphi questionnaire survey. Methods. A questionnaire listing 28 clinical, laboratory, and histopathologic features of MAS elicited by literature review was sent to 505 pediatric rheumatologists worldwide. Respondents were asked to select the 10 features that they felt were most important and useful in the diagnosis of MAS, and to order the 10 selected features by assigning the number 10 to the most important, and ending with 1 as the least important. Results. The response rate was 46% (232 physicians from 47 countries). The items selected by more than 50% of respondents were, in order of frequency, falling platelet count, hyperferritinemia, evidence of macrophage hemophagocytosis in the bone marrow, increased liver enzymes, falling leukocyte count, persistent continuous fever >= 38 degrees C, falling erythrocyte sedimentation rate, hypofibrinogenemia, and hypertriglyceridemia. Conclusion. Our process led to identification of features that were felt to be most important as candidate diagnostic criteria for MAS by a large sample of international pediatric rheumatologists. (First Release Feb 1 2011; J Rheumatol 2011;38:764-8: doi:10.3899/jrheum.100996)
引用
收藏
页码:764 / 768
页数:5
相关论文
共 50 条
  • [21] Macrophage Activation Syndrome in Patients With Systemic Juvenile Idiopathic Arthritis Treated With Tocilizumab
    Ravelli, Angelo
    Schneider, Rayfel
    Weitzman, Sheila
    Devlin, Clare
    Daimaru, Kaori
    Yokota, Shumpei
    Takei, Syuji
    De Benedetti, Fabrizio
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S83 - S84
  • [22] Methotrexate as a possible trigger of macrophage activation syndrome in systemic juvenile idiopathic arthritis
    Ravelli, A
    Caria, MC
    Buratti, S
    Malattia, C
    Temporini, F
    Martini, A
    JOURNAL OF RHEUMATOLOGY, 2001, 28 (04) : 865 - 867
  • [23] Macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis treated with tocilizumab
    Fabrizio De Benedetti
    Rayfel Schneider
    Sheila Weitzman
    Clare Devlin
    Kaori Daimaru
    Shumpei Yokota
    Syuji Takei
    Angelo Ravelli
    Pediatric Rheumatology, 12 (Suppl 1)
  • [24] MACROPHAGE ACTIVATION SYNDROME IN SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS, ONE CENTRE EXPERIENCE
    Hashad, Soad S.
    Etayari, Hala M.
    Almsellati, Iman A.
    Etfil, Majda N.
    Altwati, Aya
    Awhida, Zuhaira
    RHEUMATOLOGY, 2023, 62
  • [25] Evidence-based diagnosis and treatment of macrophage activation syndrome in systemic juvenile idiopathic arthritis
    Boom, V.
    Anton, J.
    Lahdenne, P.
    Quartier, P.
    Ravelli, A.
    Wulffraat, N. M.
    Vastert, S. J.
    PEDIATRIC RHEUMATOLOGY, 2015, 13
  • [26] Interleukin-18 for predicting the development of macrophage activation syndrome in systemic juvenile idiopathic arthritis
    Shimizu, Masaki
    Nakagishi, Yasuo
    Inoue, Natsumi
    Mizuta, Mao
    Ko, Giyo
    Saikawa, Yutaka
    Kubota, Tomohiro
    Yamasaki, Yuichi
    Takei, Syuji
    Yachie, Akihiro
    CLINICAL IMMUNOLOGY, 2015, 160 (02) : 277 - 281
  • [27] Macrophage activation syndrome in children with systemic onset juvenile idiopathic arthritis: clinical experience from northwest India
    Singh, Surjit
    Chandrakasan, Shanmuganathan
    Ahluwalia, Jasmina
    Suri, Deepti
    Rawat, Amit
    Ahmed, Nishath
    Das, Reena
    Sachdeva, M. U. S.
    Varma, Neelam
    RHEUMATOLOGY INTERNATIONAL, 2012, 32 (04) : 881 - 886
  • [28] Management of Hepatitis A-induced Macrophage Activation Syndrome With Anakinra in Systemic Juvenile Idiopathic Arthritis: A Case Report
    AlNouwaiser, Deena N.
    AlMutairi, Sajdi S.
    AlRowailey, Abdullah S.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (01)
  • [29] Rapid and Sustained Remission of Systemic Juvenile Idiopathic Arthritis-Associated Macrophage Activation Syndrome Through Treatment With Anakinra and Corticosteroids
    Bruck, Normi
    Suttorp, Meinolf
    Kabus, Maria
    Heubner, Georg
    Gahr, Manfred
    Pessler, Frank
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2011, 17 (01) : 23 - 27
  • [30] Macrophage activation syndrome as part of systemic juvenile idiopathic arthritis: diagnosis, genetics, pathophysiology and treatment
    A Ravelli
    A A Grom
    E M Behrens
    R Q Cron
    Genes & Immunity, 2012, 13 : 289 - 298